Gottesdiener Keith Michael

CIK 00016158564 companiesSOUTH SAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001615856

Recent Transactions

50 trades

Award
Septerna, Inc.$SEPN
Stock Option (Right to Buy)
2026-06-26+11,260→ 11,260 total
Award
Septerna, Inc.$SEPN
Stock Option (Right to Buy)
2025-09-25+33,246→ 33,246 total
Award
Prime Medicine, Inc.$PRME
Stock Option (right to buy)
2025-05-08+100,000→ 300,000 total
Award
Prime Medicine, Inc.$PRME
Stock Option (right to buy)
2025-02-28+500,000→ 500,000 total
Award
Prime Medicine, Inc.$PRME
Stock Option (right to buy)
2024-12-05+100,000→ 200,000 total
Gift
Prime Medicine, Inc.$PRME
Common Stock
2024-10-08−226,925→ 50,241 total
Gift
Prime Medicine, Inc.$PRME
Common Stock
2024-10-08+226,925→ 682,259 total
Gift
Prime Medicine, Inc.$PRME
Common Stock
2024-06-05−250,000→ 2,310,837 total
Gift
Prime Medicine, Inc.$PRME
Common Stock
2024-06-05+250,000→ 277,166 total
Award
Prime Medicine, Inc.$PRME
Stock Option (right to buy)
2024-02-25+100,000→ 100,000 total
Gift
Prime Medicine, Inc.$PRME
Common Stock
2023-11-11−7,500→ 2,560,837 total
Gift
Prime Medicine, Inc.$PRME
Common Stock
2023-11-11−5,000→ 27,166 total
Disposition to Issuer
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2023-11-08−3,196→ 0 total
Disposition to Issuer
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2023-11-08$19.00/sh−8,111→ 0 total
Disposition to Issuer
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2023-11-08−12,790→ 0 total
Disposition to Issuer
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2023-11-08−12,547→ 0 total
Disposition to Issuer
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2023-11-08−2,036→ 0 total
Disposition to Issuer
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2023-11-08−2,174→ 0 total
Disposition from Tender
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2023-11-08$19.00/sh−24,719→ 0 total
Disposition to Issuer
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2023-11-08−12,089→ 0 total
Disposition to Issuer
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2023-11-08−2,748→ 0 total
Disposition to Issuer
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2023-11-08−2,966→ 0 total
Award
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2023-05-24+12,547→ 12,547 total
Award
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2023-05-24+8,111→ 32,830 total
Award
Prime Medicine, Inc.$PRME
Stock Option (right to buy)
2023-03-31+497,738→ 497,738 total
Award
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2022-05-25+7,737→ 24,719 total
Award
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2022-05-25+12,790→ 12,790 total
Award
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2021-05-27+12,089→ 12,089 total
Award
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2021-05-27+7,029→ 16,982 total
Award
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2020-05-28+1,595→ 9,953 total
Award
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2020-05-28+2,966→ 2,966 total
Exercise/Conversion
RHYTHM PHARMACEUTICALS, INC.$RYTM
Common Stock
2020-03-09$6.14/sh+3,408→ 558,250 total
Exercise/Conversion
RHYTHM PHARMACEUTICALS, INC.$RYTM
Employee Stock Option (Right to Buy)
2020-03-09−3,408→ 207,877 total
Exercise/Conversion
RHYTHM PHARMACEUTICALS, INC.$RYTM
Common Stock
2020-02-10$6.14/sh+6,816→ 554,283 total
Exercise/Conversion
RHYTHM PHARMACEUTICALS, INC.$RYTM
Employee Stock Option (Right to Buy)
2020-02-10−6,816→ 211,286 total
Exercise/Conversion
RHYTHM PHARMACEUTICALS, INC.$RYTM
Common Stock
2020-01-08$4.59/sh+33,072→ 546,914 total
Exercise/Conversion
RHYTHM PHARMACEUTICALS, INC.$RYTM
Employee Stock Option (Right to Buy)
2020-01-08−33,072→ 84,208 total
Exercise/Conversion
RHYTHM PHARMACEUTICALS, INC.$RYTM
Employee Stock Option (Right to Buy)
2019-07-16−7,500→ 117,280 total
Exercise/Conversion
RHYTHM PHARMACEUTICALS, INC.$RYTM
Common Stock
2019-07-16$4.59/sh+7,500→ 513,842 total
Award
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2019-06-20+1,570→ 8,358 total
Award
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2019-06-20+2,174→ 2,174 total
Sale
RHYTHM PHARMACEUTICALS, INC.$RYTM
Common Stock
2019-03-18$30.27/sh−2,329→ 506,342 total
Sale
RHYTHM PHARMACEUTICALS, INC.$RYTM
Common Stock
2019-03-15$30.04/sh−7,961→ 508,671 total
Sale
RHYTHM PHARMACEUTICALS, INC.$RYTM
Common Stock
2019-03-14$30.05/sh−1,506→ 516,632 total
Sale
RHYTHM PHARMACEUTICALS, INC.$RYTM
Common Stock
2019-03-13$30.06/sh−7,782→ 518,138 total
Sale
RHYTHM PHARMACEUTICALS, INC.$RYTM
Common Stock
2019-02-27$30.01/sh−1,814→ 525,617 total
Sale
RHYTHM PHARMACEUTICALS, INC.$RYTM
Common Stock
2019-02-26$30.13/sh−635→ 527,431 total
Sale
RHYTHM PHARMACEUTICALS, INC.$RYTM
Common Stock
2019-02-19$30.05/sh−918→ 528,066 total
Sale
RHYTHM PHARMACEUTICALS, INC.$RYTM
Common Stock
2019-02-15$30.02/sh−12,002→ 528,984 total
Sale
RHYTHM PHARMACEUTICALS, INC.$RYTM
Common Stock
2019-02-13$30.00/sh−3,934→ 540,986 total

Companies

Recent Filings

Address

C/O SEPTERNA, INC. 250 EAST GRAND AVENUE

SOUTH SAN FRANCISCO, CA, 94080

View on SEC.gov